Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria

Kidney International

Volumn 69, Issue 1, 2006, Pages 53-59

  Ardiles, L G ^a   Loyola, F ^a   Ehrenfeld, P ^a   Burgos, M E ^a   Flores, C A ^a   Valderrama, G ^a   Caorsi, I ^a   Egido, J ^b   Mezzano, S A ^a   Figueroa, C D ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

HOE140; Hypertension; Kallikrein; Kinins; Overload proteinuria; Potassium intake

Indexed keywords

ANTIHYPERTENSIVE AGENT; BOVINE SERUM ALBUMIN; ICATIBANT; KALLIKREIN; KININ; KININ RECEPTOR B2 ANTAGONIST; POTASSIUM; PROTEIN INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; HIGH POTASSIUM INTAKE; HYDRATION; HYPERTENSION; KIDNEY PARENCHYMA; KIDNEY TUBULE DAMAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEINURIA; RAT; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 30944468564     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000005     Document Type: Article

References (41)

1. Becker GJ, Hewitson TD. The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 2000; 9: 133-138.
2. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47: 1546-1557.
3. Eddy AA. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 1996; 54 (Suppl): S49-S54.
4. Eddy AA, Kim H, Lopez-Guisa J et al. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int 2000; 58: 618-628.
5. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994; 45: 1697-1709.
6. Suzuki Y, Lopez F, Gomez G et al. Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. Am J Pathol 2001; 159: 1895-1904.
7. Thomas ME, Brunskill NJ, Harris KP et al. Proteinuria induces tubular cell turnover: a potential mechanism for tubular atrophy. Kidney Int 1999; 55: 890-898.
8. Zoja C, Donadelli R, Colleoni S et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998; 53: 1608-1615.
9. Largo R, Gomez G, Soto K et al. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33: 732-739.
10. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80.
11. Vio CP, Figueroa CD. Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int 1987; 31: 1327-1334.
12. Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR. Am J Physiol 1999; 276: F476-F484.
13. Overlack A, Stumpe KO, Moch B et al. Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertension. Klin Wochenschr 1985; 63: 352-360.
14. Alvarez V, Quiroz Y, Nava M et al. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002; 283: F1132-F1141.
15. Figueroa CD, MacIver AG, Mackenzie JC, Bhoola KD. Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 1988; 89: 437-442.
16. Carretero OA, Scicli AG. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension 1991; 18: 158-169.
17. Vio CP, Loyola S, Velarde V. Localization of components of the kallikrein-kininsystem in the kidney: relation to renal function. State Art Lect Hyperten 1992; 19: 10-16.
18. Ferri C, Bellini C, Carlomagno A et al. Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int 1994; 46: 780-788.
19. Ando T, Shimamoto K, Ura N et al. The renal kallikrein-kininsystem in renoparenquimal hypertension. Adv Exp Med Biol 1989; 247B: 127-132.
20. Cumming AD, Robson JS. Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome. Nephron 1985; 39: 206-210.
21. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733.
22. Field MJ, Giebisch GJ. Hormonal control of renal potassium excretion. Kidney Int 1985; 27: 379-387.
23. Gomez G, Largo R, Tejera N et al. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 2001; 37: 1171-1178.
24. Vio CP, Jeanneret VA. Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases. Kidney Int 2003; 64(Suppl): S57-S63.
25. Ellis D, Banner B, Janosky JE, Feig PU. Potassium supplementation attenuates experimental hypertensive renal injury. J Am Soc Nephrol 1992; 2: 1529-1537.
26. Song Q, Chao J, Chao L. High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model. Clin Exp Hypertens 1996; 18: 975-993.
27. Wang C, Ford P, Chao C et al. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat. Am J Physiol 1997; 273: F783-F789.
28. Linz W, Wiemer G, Gohlke P et al. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47: 25-49.
29. Tschope C, Gohlke P, Zhu YZ et al. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail 1997; 3: 133-148.
30. Scholkens BA. Kinins in the cardiovascular system. Immunopharmacology 1996; 33: 209-216.
31. Kim NN, Villegas S, Summerour SR, Villarreal FJ. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 1999; 31: 457-466.
32. Schanstra JP, Neau E, Drogoz P et al. In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 2002; 110: 371-379.
33. 3H-norepinephrine release in spontaneously hypertensive rats. Pharmacology 1990; 41: 67-74.
34. Miller DH, Lindley JG, Margolius HS. Tissue kallikrein levels and synthesis rates are not changed by an acute physiological dose of aldosterone. Proc Soc Exp Biol Med 1985; 180: 121-125.
35. Bliss DJ, Brewer DB. Ultrastructural localization of anionic and cationic ferritin in the rat glomerular basement membrane in protein-overload proteinuria. J Pathol 1984; 143: 57-68.
36. Davies DJ, Brewer DB. Irreversible glomerular damage following heterologous serum albumin overload. J Pathol 1977; 123: 45-52.
37. Zoja C, Perico N, Bergamelli A et al. Ticlopidine prevents renal disease progression in rats with reduced renal mass. Kidney Int 1990; 37: 934-942.
38. Ardiles L, Ehrenfeld P, Quiroz Y et al. Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats. Kidney Blood Pressure Res 2002; 25: 289-295.
39. Valdes G, Figueroa CD, Corthorn J. Temporospatial changes of kallikrein-like enzymes during the estrous cycle and pregnancy in the rat uterus. Biol Reprod 1996; 55: 236-245.
40. Amundsen E, Putter J, Friberger P et al. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979; 120A: 83-95.
41. Figueroa CD, Bhoola KD, MacIver AG, Mackenzie JC. An ontogenic study of renal tissue kallikrein in Okamoto spontaneously hypertensive rats: comparisons with human hypertensive nephropathy. Nephrol Dial Transplant 1992; 7: 516-525.